Evidence map›Paper›PMID 27706107›Full record

ReviewGenes2016

The SaeRS Two-Component System of  Staphylococcus aureus.

Qian Liu, Won-Sik Yeo, Taeok Bae

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 240 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Attenuation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Journal of bacteriology · 2025
    Article
  17. Article
  18. Calprotectin protectsmSystems · 2025
    Article
  19. Article
  20. Phosphate sensing by PhoPR regulates the cytotoxicity ofMicrobiology (Reading, England) · 2025
    Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Qian LiuDepartment of Laboratory Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. qq2005011@163.com.
Won-Sik YeoDepartment of Microbiology and Immunology, Indiana University School of Medicine-Northwest, Gary, IN 46408, USA. wonyeo@iu.edu.
Taeok BaeDepartment of Microbiology and Immunology, Indiana University School of Medicine-Northwest, Gary, IN 46408, USA. tbae@iun.edu.
Indiana University Northwest · USIndiana University School of MedicineShanghai Jiao Tong University · CN

Funding

Development of anti-virulence drugs by targeting the SaeRS two component system of Staphylococcus aureusR21AI121664 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI BAE, TAEOK · 2016 to 2017
$374k
NIAID NIH HHS R21 AI121664
6 · The paper itself

Abstract

In the Gram-positive pathogenic bacterium Staphylococcus aureus, the SaeRS twocomponent system (TCS) plays a major role in controlling the production of over 20 virulence factors including hemolysins, leukocidins, superantigens, surface proteins, and proteases. The SaeRS TCS is composed of the sensor histidine kinase SaeS, response regulator SaeR, and two auxiliary proteins SaeP and SaeQ. Since its discovery in 1994, the sae locus has been studied extensively, and its contributions to staphylococcal virulence and pathogenesis have been well documented and understood; however, the molecular mechanism by which the SaeRS TCS receives and processes cognate signals is not. In this article, therefore, we review the literature focusing on the signaling mechanism and its interaction with other global regulators.

Indexed as

Bacterial histidine  kinaseStaphylococcus aureusTwo‐component systemVirulence factors

Identifiers

PMID27706107
PMCPMC5083920
OpenAlexW2528158691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.